Pain Crisis
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Safety of Rivipansel (GMI-1070) in the Treatment of One or More Vaso-Occlusive Crises in Hospitalized Subjects With Sickle Cell Disease (NCT02433158) | GlycoMimetics Incorporated | 2015-12-16 |
| Study of GMI-1070 for the Treatment of Sickle Cell Pain Crisis (NCT01119833) | GlycoMimetics Incorporated | 2010-05-01 |
| Natural History of Sickle Cell Disease (NCT00081523) | National Heart, Lung, and Blood Institute (NHLBI) | 2004-04-29 |
Track Pain Crisis automatically
Every clearance here is in the API, with alerts when new ones post.